世界のリンパ腫分子診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Lymphoma Molecular Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4449 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、リンパ腫分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・リンパ腫分子診断の市場動向 ・企業の競争状況、市場シェア ・リンパ腫分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ） ・リンパ腫分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究） ・リンパ腫分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・リンパ腫分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・リンパ腫分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・リンパ腫分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・リンパ腫分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Genetech、Gene+、Annoroad、Unitedgene、Inmedi、Sansure、SinoMD、San Valley、Premed） ・結論

A molecular approach for diagnosing lymphoma

Market Analysis and Insights: Global Lymphoma Molecular Diagnostics Market
The global Lymphoma Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lymphoma Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lymphoma Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lymphoma Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lymphoma Molecular Diagnostics market.

Global Lymphoma Molecular Diagnostics Scope and Market Size
Lymphoma Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lymphoma Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip

Segment by Application
Clinical Diagnosis
Drug Screening
Research

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Genetech
Gene+
Annoroad
Unitedgene
Inmedi
Sansure
SinoMD
San Valley
Premed

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lymphoma Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Lymphoma Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lymphoma Molecular Diagnostics Market Perspective (2016-2027)
2.2 Lymphoma Molecular Diagnostics Growth Trends by Regions
2.2.1 Lymphoma Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lymphoma Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Lymphoma Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Lymphoma Molecular Diagnostics Industry Dynamic
2.3.1 Lymphoma Molecular Diagnostics Market Trends
2.3.2 Lymphoma Molecular Diagnostics Market Drivers
2.3.3 Lymphoma Molecular Diagnostics Market Challenges
2.3.4 Lymphoma Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lymphoma Molecular Diagnostics Players by Revenue
3.1.1 Global Top Lymphoma Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Lymphoma Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Lymphoma Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lymphoma Molecular Diagnostics Revenue
3.4 Global Lymphoma Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Lymphoma Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lymphoma Molecular Diagnostics Revenue in 2020
3.5 Lymphoma Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Lymphoma Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Lymphoma Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lymphoma Molecular Diagnostics Breakdown Data by Type
4.1 Global Lymphoma Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Lymphoma Molecular Diagnostics Forecasted Market Size by Type (2022-2027)

5 Lymphoma Molecular Diagnostics Breakdown Data by Application
5.1 Global Lymphoma Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Lymphoma Molecular Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lymphoma Molecular Diagnostics Market Size (2016-2027)
6.2 North America Lymphoma Molecular Diagnostics Market Size by Type
6.2.1 North America Lymphoma Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Lymphoma Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Lymphoma Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Lymphoma Molecular Diagnostics Market Size by Application
6.3.1 North America Lymphoma Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Lymphoma Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Lymphoma Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Lymphoma Molecular Diagnostics Market Size by Country
6.4.1 North America Lymphoma Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Lymphoma Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Lymphoma Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Lymphoma Molecular Diagnostics Market Size by Type
7.2.1 Europe Lymphoma Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Lymphoma Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Lymphoma Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Lymphoma Molecular Diagnostics Market Size by Application
7.3.1 Europe Lymphoma Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Lymphoma Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Lymphoma Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Lymphoma Molecular Diagnostics Market Size by Country
7.4.1 Europe Lymphoma Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Lymphoma Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lymphoma Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lymphoma Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Lymphoma Molecular Diagnostics Market Size by Type
9.2.1 Latin America Lymphoma Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Lymphoma Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Lymphoma Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Lymphoma Molecular Diagnostics Market Size by Application
9.3.1 Latin America Lymphoma Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Lymphoma Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Lymphoma Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Lymphoma Molecular Diagnostics Market Size by Country
9.4.1 Latin America Lymphoma Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Lymphoma Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lymphoma Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Genetech
11.1.1 Genetech Company Details
11.1.2 Genetech Business Overview
11.1.3 Genetech Lymphoma Molecular Diagnostics Introduction
11.1.4 Genetech Revenue in Lymphoma Molecular Diagnostics Business (2016-2021)
11.1.5 Genetech Recent Development
11.2 Gene+
11.2.1 Gene+ Company Details
11.2.2 Gene+ Business Overview
11.2.3 Gene+ Lymphoma Molecular Diagnostics Introduction
11.2.4 Gene+ Revenue in Lymphoma Molecular Diagnostics Business (2016-2021)
11.2.5 Gene+ Recent Development
11.3 Annoroad
11.3.1 Annoroad Company Details
11.3.2 Annoroad Business Overview
11.3.3 Annoroad Lymphoma Molecular Diagnostics Introduction
11.3.4 Annoroad Revenue in Lymphoma Molecular Diagnostics Business (2016-2021)
11.3.5 Annoroad Recent Development
11.4 Unitedgene
11.4.1 Unitedgene Company Details
11.4.2 Unitedgene Business Overview
11.4.3 Unitedgene Lymphoma Molecular Diagnostics Introduction
11.4.4 Unitedgene Revenue in Lymphoma Molecular Diagnostics Business (2016-2021)
11.4.5 Unitedgene Recent Development
11.5 Inmedi
11.5.1 Inmedi Company Details
11.5.2 Inmedi Business Overview
11.5.3 Inmedi Lymphoma Molecular Diagnostics Introduction
11.5.4 Inmedi Revenue in Lymphoma Molecular Diagnostics Business (2016-2021)
11.5.5 Inmedi Recent Development
11.6 Sansure
11.6.1 Sansure Company Details
11.6.2 Sansure Business Overview
11.6.3 Sansure Lymphoma Molecular Diagnostics Introduction
11.6.4 Sansure Revenue in Lymphoma Molecular Diagnostics Business (2016-2021)
11.6.5 Sansure Recent Development
11.7 SinoMD
11.7.1 SinoMD Company Details
11.7.2 SinoMD Business Overview
11.7.3 SinoMD Lymphoma Molecular Diagnostics Introduction
11.7.4 SinoMD Revenue in Lymphoma Molecular Diagnostics Business (2016-2021)
11.7.5 SinoMD Recent Development
11.8 San Valley
11.8.1 San Valley Company Details
11.8.2 San Valley Business Overview
11.8.3 San Valley Lymphoma Molecular Diagnostics Introduction
11.8.4 San Valley Revenue in Lymphoma Molecular Diagnostics Business (2016-2021)
11.8.5 San Valley Recent Development
11.9 Premed
11.9.1 Premed Company Details
11.9.2 Premed Business Overview
11.9.3 Premed Lymphoma Molecular Diagnostics Introduction
11.9.4 Premed Revenue in Lymphoma Molecular Diagnostics Business (2016-2021)
11.9.5 Premed Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Lymphoma Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Lymphoma Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Lymphoma Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Lymphoma Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Lymphoma Molecular Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Lymphoma Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Lymphoma Molecular Diagnostics Market Share by Regions (2022-2027)
Table 12. Lymphoma Molecular Diagnostics Market Trends
Table 13. Lymphoma Molecular Diagnostics Market Drivers
Table 14. Lymphoma Molecular Diagnostics Market Challenges
Table 15. Lymphoma Molecular Diagnostics Market Restraints
Table 16. Global Lymphoma Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Lymphoma Molecular Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Lymphoma Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lymphoma Molecular Diagnostics as of 2020)
Table 19. Ranking of Global Top Lymphoma Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Lymphoma Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Lymphoma Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Lymphoma Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lymphoma Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Lymphoma Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Lymphoma Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Lymphoma Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Lymphoma Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Lymphoma Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Lymphoma Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Lymphoma Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Lymphoma Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Lymphoma Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Lymphoma Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Lymphoma Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Lymphoma Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Lymphoma Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Lymphoma Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Lymphoma Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Lymphoma Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Lymphoma Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Lymphoma Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Lymphoma Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Lymphoma Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Lymphoma Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Lymphoma Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Lymphoma Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Lymphoma Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Lymphoma Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Lymphoma Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Lymphoma Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Genetech Company Details
Table 64. Genetech Business Overview
Table 65. Genetech Lymphoma Molecular Diagnostics Product
Table 66. Genetech Revenue in Lymphoma Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Genetech Recent Development
Table 68. Gene+ Company Details
Table 69. Gene+ Business Overview
Table 70. Gene+ Lymphoma Molecular Diagnostics Product
Table 71. Gene+ Revenue in Lymphoma Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Gene+ Recent Development
Table 73. Annoroad Company Details
Table 74. Annoroad Business Overview
Table 75. Annoroad Lymphoma Molecular Diagnostics Product
Table 76. Annoroad Revenue in Lymphoma Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Annoroad Recent Development
Table 78. Unitedgene Company Details
Table 79. Unitedgene Business Overview
Table 80. Unitedgene Lymphoma Molecular Diagnostics Product
Table 81. Unitedgene Revenue in Lymphoma Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Unitedgene Recent Development
Table 83. Inmedi Company Details
Table 84. Inmedi Business Overview
Table 85. Inmedi Lymphoma Molecular Diagnostics Product
Table 86. Inmedi Revenue in Lymphoma Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Inmedi Recent Development
Table 88. Sansure Company Details
Table 89. Sansure Business Overview
Table 90. Sansure Lymphoma Molecular Diagnostics Product
Table 91. Sansure Revenue in Lymphoma Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Sansure Recent Development
Table 93. SinoMD Company Details
Table 94. SinoMD Business Overview
Table 95. SinoMD Lymphoma Molecular Diagnostics Product
Table 96. SinoMD Revenue in Lymphoma Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 97. SinoMD Recent Development
Table 98. San Valley Company Details
Table 99. San Valley Business Overview
Table 100. San Valley Revenue in Lymphoma Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 101. San Valley Recent Development
Table 102. Premed Company Details
Table 103. Premed Business Overview
Table 104. Premed Lymphoma Molecular Diagnostics Product
Table 105. Premed Revenue in Lymphoma Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Premed Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lymphoma Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Lymphoma Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Lymphoma Molecular Diagnostics Report Years Considered
Figure 11. Global Lymphoma Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Lymphoma Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Lymphoma Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Lymphoma Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Lymphoma Molecular Diagnostics Market Share by Players in 2020
Figure 16. Global Top Lymphoma Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lymphoma Molecular Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Lymphoma Molecular Diagnostics Revenue in 2020
Figure 18. Global Lymphoma Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Lymphoma Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Lymphoma Molecular Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Lymphoma Molecular Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Lymphoma Molecular Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Lymphoma Molecular Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Lymphoma Molecular Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Lymphoma Molecular Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Lymphoma Molecular Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Lymphoma Molecular Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Lymphoma Molecular Diagnostics Market Share by Region (2016-2027)
Figure 40. China Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Lymphoma Molecular Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Lymphoma Molecular Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Lymphoma Molecular Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Lymphoma Molecular Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Lymphoma Molecular Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Lymphoma Molecular Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Lymphoma Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Genetech Revenue Growth Rate in Lymphoma Molecular Diagnostics Business (2016-2021)
Figure 60. Gene+ Revenue Growth Rate in Lymphoma Molecular Diagnostics Business (2016-2021)
Figure 61. Annoroad Revenue Growth Rate in Lymphoma Molecular Diagnostics Business (2016-2021)
Figure 62. Unitedgene Revenue Growth Rate in Lymphoma Molecular Diagnostics Business (2016-2021)
Figure 63. Inmedi Revenue Growth Rate in Lymphoma Molecular Diagnostics Business (2016-2021)
Figure 64. Sansure Revenue Growth Rate in Lymphoma Molecular Diagnostics Business (2016-2021)
Figure 65. SinoMD Revenue Growth Rate in Lymphoma Molecular Diagnostics Business (2016-2021)
Figure 66. San Valley Revenue Growth Rate in Lymphoma Molecular Diagnostics Business (2016-2021)
Figure 67. Premed Revenue Growth Rate in Lymphoma Molecular Diagnostics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---